Cite
HARVARD Citation
Pietri, E. et al. (2015). A Phase II Study of a Dose‐Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer. Oncologist. pp. 239-240. [Online].